Azienda Universitaria Ospedaliera Consorziale Policlinico Bari

Bari 70124

5 studies enrolling now · 7 studies all time

What they study most

Extrapulmonary Neuroendocrine Cancer (epNEC), Focal Segmental Glomerulosclerosis, Kidney Disease, Chronic, Neuroendocrine Tumour of the Lung, Neuroendocrine Tumours, Proteinuric Kidney Diseases, Small Intestinal NET, Systemic Sclerosis, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
• Open-Label Surufatinib in European Patients With NET — Stopped early